SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+24.18%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$840M
AUM Growth
+$840M
(+39%)
Cap. Flow
+$94.3M
Cap. Flow
% of AUM
11.22%
Top 10 Holdings %
Top 10 Hldgs %
49.44%
Holding
116
New
35
Increased
16
Reduced
23
Closed
30
Top Buys
| 1 |
AbbVie
ABBV
|
$55.9M |
| 2 |
Nice
NICE
|
$24.5M |
| 3 |
Amgen
AMGN
|
$18.9M |
| 4 |
AstraZeneca
AZN
|
$16.9M |
| 5 |
Eli Lilly
LLY
|
$14.8M |
Top Sells
| 1 |
Larimar Therapeutics
LRMR
|
$35.5M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$22.4M |
| 3 |
Sarepta Therapeutics
SRPT
|
$21.6M |
| 4 |
Pfizer
PFE
|
$18M |
| 5 |
Novo Nordisk
NVO
|
$11.5M |
Sector Composition
| 1 | Healthcare | 81.38% |
| 2 | Technology | 10.39% |
| 3 | Consumer Discretionary | 2.06% |
| 4 | Industrials | 1.78% |
| 5 | Communication Services | 1.47% |
